Literature DB >> 21266457

Partial recessive IFN-γR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds.

Ithaisa Sologuren1, Stéphanie Boisson-Dupuis, Jose Pestano, Quentin Benoit Vincent, Leandro Fernández-Pérez, Ariane Chapgier, María Cárdenes, Jacqueline Feinberg, M Isabel García-Laorden, Capucine Picard, Esther Santiago, Xiaofei Kong, Lucile Jannière, Elena Colino, Estefanía Herrera-Ramos, Adela Francés, Carmen Navarrete, Stéphane Blanche, Emilia Faria, Pawel Remiszewski, Ana Cordeiro, Alexandra Freeman, Steven Holland, Katia Abarca, Mónica Valerón-Lemaur, José Gonçalo-Marques, Luisa Silveira, José Manuel García-Castellano, José Caminero, José Luis Pérez-Arellano, Jacinta Bustamante, Laurent Abel, Jean-Laurent Casanova, Carlos Rodríguez-Gallego.   

Abstract

We report a series of 14 patients from 11 kindreds with recessive partial (RP)-interferon (IFN)-γR1 deficiency. The I87T mutation was found in nine homozygous patients from Chile, Portugal and Poland, and the V63G mutation was found in five homozygous patients from the Canary Islands. Founder effects accounted for the recurrence of both mutations. The most recent common ancestors of the patients with the I87T and V63G mutations probably lived 1600 (875-2950) and 500 (200-1275) years ago, respectively. The two alleles confer phenotypes that are similar but differ in terms of IFN-γR1 levels and residual response to IFN-γ. The patients suffered from bacillus Calmette-Guérin-osis (n= 6), environmental mycobacteriosis (n= 6) or tuberculosis (n= 1). One patient did not suffer from mycobacterial infections but had disseminated salmonellosis, which was also present in two other patients. Age at onset of the first environmental mycobacterial disease differed widely between patients, with a mean value of 11.25 ± 9.13 years. Thirteen patients survived until the age of 14.82 ± 11.2 years, and one patient died at the age of 7 years, 9 days after the diagnosis of long-term Mycobacterium avium infection and the initiation of antimycobacterial treatment. Up to 10 patients are currently free of infection with no prophylaxis. The clinical heterogeneity of the 14 patients was not clearly related to either IFNGR1 genotype or the resulting cellular phenotype. RP-IFN-γR1 deficiency is, thus, more common than initially thought and should be considered in both children and adults with mild or severe mycobacterial diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21266457      PMCID: PMC3115578          DOI: 10.1093/hmg/ddr029

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  53 in total

1.  Signature of recent historical events in the European Y-chromosomal STR haplotype distribution.

Authors:  Lutz Roewer; Peter J P Croucher; Sascha Willuweit; Tim T Lu; Manfred Kayser; Rüdiger Lessig; Peter de Knijff; Mark A Jobling; Chris Tyler-Smith; Michael Krawczak
Journal:  Hum Genet       Date:  2005-01-20       Impact factor: 4.132

2.  Tuberculosis in children and adults: two distinct genetic diseases.

Authors:  Alexandre Alcaïs; Claire Fieschi; Laurent Abel; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2005-12-19       Impact factor: 14.307

3.  A causative relationship between mutant IFNgR1 alleles and impaired cellular response to IFNgamma in a compound heterozygous child.

Authors:  F Altare; E Jouanguy; S Lamhamedi-Cherradi; M C Fondanéche; C Fizame; F Ribiérre; G Merlin; Z Dembic; R Schreiber; B Lisowska-Grospierre; A Fischer; E Seboun; J L Casanova
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

Review 4.  Defects in the interferon-gamma and interleukin-12 pathways.

Authors:  Sergio D Rosenzweig; Steven M Holland
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

5.  Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis.

Authors:  E Jouanguy; S Lamhamedi-Cherradi; F Altare; M C Fondanèche; D Tuerlinckx; S Blanche; J F Emile; J L Gaillard; R Schreiber; M Levin; A Fischer; C Hivroz; J L Casanova
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

6.  Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional survey.

Authors:  Joachim Roesler; Mitchell E Horwitz; Capucine Picard; Pierre Bordigoni; Graham Davies; Ewa Koscielniak; Mike Levin; Paul Veys; Ursula Reuter; Ansgar Schulz; Christian Thiede; Thomas Klingebiel; Alain Fischer; Steven M Holland; Jean-Laurent Casanova; Wilhelm Friedrich
Journal:  J Pediatr       Date:  2004-12       Impact factor: 4.406

7.  Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies.

Authors:  Susan E Dorman; Capucine Picard; David Lammas; Klaus Heyne; Jaap T van Dissel; Richard Baretto; Sergio D Rosenzweig; Melanie Newport; Michael Levin; Joachim Roesler; Dinakantha Kumararatne; Jean-Laurent Casanova; Steven M Holland
Journal:  Lancet       Date:  2004 Dec 11-17       Impact factor: 79.321

8.  Detection of intracellular phosphorylated STAT-1 by flow cytometry.

Authors:  T A Fleisher; S E Dorman; J A Anderson; M Vail; M R Brown; S M Holland
Journal:  Clin Immunol       Date:  1999-03       Impact factor: 3.969

Review 9.  Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options.

Authors:  J Roesler; B Kofink; J Wendisch; S Heyden; D Paul; W Friedrich; J L Casanova; W Leupold; M Gahr; A Rösen-Wolff
Journal:  Exp Hematol       Date:  1999-09       Impact factor: 3.084

10.  Bacillus Calmette Guerin triggers the IL-12/IFN-gamma axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes.

Authors:  Jacqueline Feinberg; Claire Fieschi; Rainer Doffinger; Max Feinberg; Tony Leclerc; Stéphanie Boisson-Dupuis; Capucine Picard; Jacinta Bustamante; Ariane Chapgier; Orchidée Filipe-Santos; Cheng-Lung Ku; Ludovic de Beaucoudrey; Janine Reichenbach; Guillemette Antoni; Ramatoulaye Baldé; Alexandre Alcaïs; Jean-Laurent Casanova
Journal:  Eur J Immunol       Date:  2004-11       Impact factor: 5.532

View more
  43 in total

1.  No significant impact of IFN-γ pathway gene variants on tuberculosis susceptibility in a West African population.

Authors:  Christian G Meyer; Christopher D Intemann; Birgit Förster; Ellis Owusu-Dabo; Andre Franke; Rolf D Horstmann; Thorsten Thye
Journal:  Eur J Hum Genet       Date:  2015-08-05       Impact factor: 4.246

2.  Inherited human IFN-γ deficiency underlies mycobacterial disease.

Authors:  Gaspard Kerner; Jérémie Rosain; Antoine Guérin; Ahmad Al-Khabaz; Carmen Oleaga-Quintas; Franck Rapaport; Michel J Massaad; Jing-Ya Ding; Taushif Khan; Fatima Al Ali; Mahbuba Rahman; Caroline Deswarte; Rubén Martinez-Barricarte; Raif S Geha; Valentine Jeanne-Julien; Diane Garcia; Chih-Yu Chi; Rui Yang; Manon Roynard; Bernhard Fleckenstein; Flore Rozenberg; Stéphanie Boisson-Dupuis; Cheng-Lung Ku; Yoann Seeleuthner; Vivien Béziat; Nico Marr; Laurent Abel; Waleed Al-Herz; Jean-Laurent Casanova; Jacinta Bustamante
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 3.  Diagnostic and therapeutic challenges in a child with complete interferon-γ receptor 1 deficiency.

Authors:  Peter Olbrich; Maria Teresa Martínez-Saavedra; José Maria Perez-Hurtado; Cristina Sanchez; Berta Sanchez; Caroline Deswarte; Ignacio Obando; Jean-Laurent Casanova; Carsten Speckmann; Jacinta Bustamante; Carlos Rodriguez-Gallego; Olaf Neth
Journal:  Pediatr Blood Cancer       Date:  2015-07-14       Impact factor: 3.167

4.  B-cell lymphoma in a patient with complete interferon gamma receptor 1 deficiency.

Authors:  Hannelore I Bax; Alexandra F Freeman; Victoria L Anderson; Per Vesterhus; Dan Laerum; Stefania Pittaluga; Wyndham H Wilson; Steven M Holland
Journal:  J Clin Immunol       Date:  2013-06-26       Impact factor: 8.317

5.  Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.

Authors:  Toidi Adekambi; Chris C Ibegbu; Stephanie Cagle; Ameeta S Kalokhe; Yun F Wang; Yijuan Hu; Cheryl L Day; Susan M Ray; Jyothi Rengarajan
Journal:  J Clin Invest       Date:  2015-03-30       Impact factor: 14.808

Review 6.  Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases.

Authors:  Sayna Norouzi; Asghar Aghamohammadi; Setareh Mamishi; Sergio D Rosenzweig; Nima Rezaei
Journal:  J Infect       Date:  2012-03-16       Impact factor: 6.072

7.  Impaired cytokine responses in patients with cryopyrin-associated periodic syndrome (CAPS).

Authors:  M H Haverkamp; E van de Vosse; R Goldbach-Mansky; S M Holland
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

8.  Identification of a major epitope by anti-interferon-γ autoantibodies in patients with mycobacterial disease.

Authors:  Chia-Hao Lin; Chih-Yu Chi; Han-Po Shih; Jing-Ya Ding; Chia-Chi Lo; Shang-Yu Wang; Chen-Yen Kuo; Chun-Fu Yeh; Kun-Hua Tu; Shou-Hsuan Liu; Hung-Kai Chen; Chen-Hsuan Ho; Mao-Wang Ho; Chen-Hsiang Lee; Hsin-Chin Lai; Cheng-Lung Ku
Journal:  Nat Med       Date:  2016-08-15       Impact factor: 53.440

9.  Overexpression of methyl-CpG binding protein 2 impairs T(H)1 responses.

Authors:  Tianshu Yang; Melissa B Ramocki; Jeffrey L Neul; Wen Lu; Luz Roberts; John Knight; Christopher S Ward; Huda Y Zoghbi; Farrah Kheradmand; David B Corry
Journal:  Sci Transl Med       Date:  2012-12-05       Impact factor: 17.956

10.  Heterozygosity for the Y701C STAT1 mutation in a multiplex kindred with multifocal osteomyelitis.

Authors:  Osamu Hirata; Satoshi Okada; Miyuki Tsumura; Reiko Kagawa; Mizuka Miki; Hiroshi Kawaguchi; Kazuhiro Nakamura; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova; Yoshihiro Takihara; Masao Kobayashi
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.